The 20 Best PIK3CA-Related Overgrowth Spectrum Doctors Near Me in Massachusetts, US

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Aditya Bardia is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bardia is rated as an Elite provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Agranulocytosis, and Tissue Biopsy.

Dejan Juric is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Juric is rated as an Elite provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, HER2 Negative Breast Cancer, Tissue Biopsy, and Lithotripsy.

Dr. Sammons is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer. She has led multiple clinical trials which have led to new treatment options for patients with metastatic breast cancer. She also has expertise in the treatment of brain metastases. Dr. Sammons received her MD from Sidney Kimmel Medical College in Philadelphia, PA in 2012. She completed her residency in internal medicine at University of Maryland and went on to complete fellowship in medical oncology and hematology at Duke University. In 2018, she joined the staff of Duke Cancer Institute and ultimately served as Associate Director of Breast Cancer Research. She joined Brigham and Women's and Dana-Farber in 2022, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. She serves as Associate Director of the Metastatic Breast Cancer Program. Dr. Sammons is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Paget Disease of the Breast. Dr. Sammons is board certified in Internal Medicine and Medical Oncology.

Jeffrey Meyerhardt is an Oncologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Meyerhardt is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Meyerhardt is board certified in Medical Oncology.

Ursula Matulonis is an Oncologist practicing medicine in South Weymouth, Massachusetts. Dr. Matulonis is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Tubal Ligation. Dr. Matulonis is board certified in Internal Medicine and Medical Oncology.

Samuel Klempner is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Klempner is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Esophageal Cancer, Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, and Tissue Biopsy.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Mayer is board certified in Medical Oncology.

Gerburg Wulf is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Wulf is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is board certified in American Board Of Internal Medicine.

Nolan Priedigkeit, MD, PhD is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Instructor of Medicine at Harvard Medical School. Clinically, he specializes in breast cancer and his research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat metastatic disease. He received dual MD/PhD degrees from the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program where his thesis applied translational genomics to discover novel drug targets in advanced breast cancers. He completed an internal medicine residency at Brigham & Women’s Hospital, a medical oncology fellowship at Dana-Farber/Mass General Brigham, and currently leads multidisciplinary research projects at the Broad Institute of MIT & Harvard focused exclusively on breast cancer. He has been supported by awards from the National Cancer Institute, American Association for Cancer Research, Conquer Cancer Foundation of ASCO, Lubin Family Foundation, and the Susan G. Komen Foundation. He values patient-centered care with a focus on open and transparent communication, generous sharing of research data and ideas, as well as mentorship of trainees in both science and medicine. Dr. Priedigkeit is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Metastatic Brain Tumor. Dr. Priedigkeit is board certified in Internal Medicine.

Theodore Hong is a Radiologist practicing medicine in Needham, Massachusetts. Dr. Hong is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Hong is board certified in American Board Of Radiology.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Lynce is board certified in Medical Oncology.

Dr. Metzger received his MD from Federal University of Minas Gerais in 2003 and completed training in Internal Medicine and Medical Oncology in 2008. Following his formal training, he spent three years at the Institute Jules Bordet in Brussels where he completed a research fellowship and initiated a career dedicated to understanding the biological features of the second most common histological subtype of breast cancer - invasive lobular carcinoma. Since joining the Breast Oncology Program at Dana-Farber Cancer Institute in 2012, he has established an active clinical practice and developed research efforts focused on identifying better treatment strategies for patients diagnosed with breast cancer. He is involved in designing and leading national and international clinical trials with a strong translational component. In addition to his physician and clinical investigator roles, Dr. Metzger holds an Executive Officer position at the Alliance for Clinical Trials in Oncology. Dr. Metzger is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and HER-2 Positive Breast Cancer.

Charles Fuchs is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Fuchs is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Gastroesophageal Junction Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Colonoscopy.

Andrew Chan is a Gastroenterologist practicing medicine in Boston, Massachusetts. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Diverticular Disease, Familial Colorectal Cancer, Colonoscopy, and Endoscopy.

Marios Giannakis is an Oncologist practicing medicine in Boston, Massachusetts. He has been practicing medicine for over 17 years. Dr. Giannakis is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Familial Colorectal Cancer, and Pancreatic Cancer.

Brian Alexander is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Alexander is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.

Steven Isakoff is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Isakoff is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.

Bruce Johnson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer.